Automated Dried Blood Spot Method Boosts Doping Agent Detection
Background
Doping control in sports is critical for fair competition and athlete health, requiring highly sensitive and efficient analytical methods. Traditional approaches for detecting performance-enhancing drugs often involve invasive blood draws and labor-intensive sample preparation, which can limit throughput and accessibility. This study addresses the need for a more efficient, less invasive, and highly sensitive method for detecting a broad range of doping agents, including lower molecular mass peptides and non-peptide substances, from minimal sample volumes.
Results
The automated DBS method demonstrated significantly enhanced detection capabilities for a wide range of doping agents, offering substantial improvements over manual techniques. For lower molecular mass peptides, the method achieved impressive detection limits as low as 0.1 ng/mL, representing a 2-fold improvement in sensitivity compared to conventional manual methods. Non-peptide doping agents consistently showed high recoveries, ranging from 75% to 95%, with excellent inter-day precision below 10% RSD. The method's linearity was confirmed across a concentration range spanning two orders of magnitude, with R² values consistently above 0.99. This allowed for the simultaneous detection of over 50 different doping substances, including various anabolic agents and hormones, within a single analytical run. The fully automated system achieved a 30% reduction in sample preparation time and a 5-fold increase in sample throughput compared to conventional manual techniques, while maintaining high analytical sensitivity and specificity.
Why It Matters
This fully automated DBS-LC-HRMS method represents a significant advancement in anti-doping analysis, offering a less invasive, more efficient, and highly sensitive approach for detecting illicit substances. The ability to detect a broader spectrum of doping agents from minimal blood volumes could revolutionize large-scale screening programs and targeted investigations, making testing more accessible and cost-effective. This technology could be rapidly implemented in anti-doping laboratories worldwide, leading to more effective and timely detection of illicit substances in athletes and promoting fairer sports. Future steps include extensive validation in real-world athlete samples and expanding the panel of detectable substances to include emerging doping threats.